Literature DB >> 11428855

Rarefaction of skin capillaries in patients with anginal chest pain and normal coronary arteriograms.

T F Antonios1, J C Kaski, K M Hasan, S J Brown, D R Singer.   

Abstract

AIMS: Patients with arterial hypertension often have a reduction in capillary density (rarefaction) and a reduction in coronary flow reserve because of functional and structural alterations of the coronary microcirculation. Patients with chest pain and normal coronary arteriograms may have coronary microvascular dysfunction, but it is not known whether capillary rarefaction plays a role in the pathogenesis of this syndrome. The aim of this study was to compare capillary density in hypertensive and normotensive subjects with anginal chest pain and normal coronary arteriograms vs asymptomatic hypertensives and healthy controls. METHODS AND
RESULTS: We studied 49 patients with typical anginal chest pain, positive exercise testing and normal coronary arteriograms; 22 were hypertensive and 27 were normotensive. We used intra-vital video-microscopy to examine the skin of the dorsum of the middle finger of the non-dominant hand before and after maximization of perfused capillaries with venous congestion. Mean capillary density was significantly lower in patients with chest pain and normal coronary arteriograms independent of their blood pressure level, compared to normotensive healthy controls. Differences were found both at baseline [51+/-2 (hypertensive) and 52+/-2 (normotensive) vs 65+/-2 (controls) per 0.56 mm(2) respectively], (P<0.0001) and after maximization [57+/-3 (hypertensive) and 59+/-2 (normotensive) versus 75+/-3 (controls) respectively] (P<0.0001).
CONCLUSIONS: Skin capillary density is significantly lower in patients with chest pain and normal coronary arteriograms compared to normotensive controls. The pathophysiological importance of capillary rarefaction in patients with chest pain and normal coronary arteriograms remains unknown. Further studies are needed to determine whether the abnormality is associated with myocardial flow disturbances such that the findings can be extended to the heart. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Year:  2001        PMID: 11428855     DOI: 10.1053/euhj.2000.2442

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  17 in total

1.  Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension.

Authors:  T F T Antonios; F M Rattray; D R J Singer; N D Markandu; P S Mortimer; G A MacGregor
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

2.  Syndrome X and microvascular coronary dysfunction.

Authors:  C Noel Bairey Merz; Carl J Pepine
Journal:  Circulation       Date:  2011-09-27       Impact factor: 29.690

Review 3.  Capillary rarefaction as an index for the microvascular assessment of hypertensive patients.

Authors:  Areti Triantafyllou; Panagiota Anyfanti; Athina Pyrpasopoulou; Georgios Triantafyllou; Spyros Aslanidis; Stella Douma
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

Review 4.  Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests.

Authors:  Hernán Mejía-Rentería; Nina van der Hoeven; Tim P van de Hoef; Julius Heemelaar; Nicola Ryan; Amir Lerman; Niels van Royen; Javier Escaned
Journal:  Int J Cardiovasc Imaging       Date:  2017-05-13       Impact factor: 2.357

5.  Characterization of skin dermis microcirculation in flow-mediated dilation using optical sensor with pressurization mechanism.

Authors:  Yoshiki Yamakoshi; Kazuhiko Kotani; Nobuyuki Taniguchi; Takashi Miwa
Journal:  Med Biol Eng Comput       Date:  2012-12-29       Impact factor: 2.602

6.  Decreased serum osteoprotegerin levels in patients with cardiac syndrome X.

Authors:  A Altun; B Ugur-Altun; E Tatli
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

7.  Endothelial function in patients with slow coronary flow and normal coronary angiography.

Authors:  Luis Ulisses Signori; Alexandre Schaan de Quadros; Graciele Sbruzzi; Thiago Dipp; Renato D Lopes; Beatriz D'Agord Schaan
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

8.  Treatment of essential hypertension does not normalize capillary rarefaction.

Authors:  Guilherme Loures de Araújo Penna; Rodrigo de Freitas Garbero; Mario Fritsch Neves; Wille Oigman; Daniel Alexandre Bottino; Eliete Bouskela
Journal:  Clinics (Sao Paulo)       Date:  2008-10       Impact factor: 2.365

9.  α-Tocopherol Improves Microcirculatory Dysfunction on Fructose Fed Hamsters.

Authors:  Beatriz C S Boa; Carlos M M R Barros; Maria das Graças C Souza; Raquel C Castiglione; Fátima Z G A Cyrino; Eliete Bouskela
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

10.  Doppler flowmetry as a tool of predictive, preventive and personalised dentistry.

Authors:  Liudmila Yu Orekhova; Anna A Barmasheva
Journal:  EPMA J       Date:  2013-08-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.